Daxor Corporation (DXR)
NASDAQ · Manufacturing · Surgical & medical instruments & apparatus
$11.01−$0.3800 (−3.34%) on the dayAs of the close; data may be delayed.
DXR price, last 12 months
Key stats
- Previous close
- $11.39
- Open
- $11.41
- Day range
- $10.46 – $11.41
- 52-week range
- $8.56 – $14.76
- Volume
- 16.4K
- Avg volume (20 days)
- 44.8K
- Market cap
- $64.3M
Performance
1W−3.8%
1M+9.8%
3M+17.1%
6M−4.3%
YTD−25.4%
1Y+0.1%
vs S&P 500, 1Y−16.7 pts
Technicals and fundamentals
About Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system. The company operates as a single business segment centered on the development, commercialization, and support of its proprietary blood volume analysis technology used by healthcare providers.
- Sector
- Manufacturing
- Industry
- Surgical & medical instruments & apparatus
- Listed on
- NASDAQ
- Market cap
- $64.3M